Freespira named one of Fast Company's 2023 Most Innovative Companies.

Bringing Medication-Free Options to Patients of Panic Disorders with Joe Perekupka and Dr. Robert Cuyler

MarketScale

PTSD affects 6.1-9.2% of the adult US population (Up To Date). Additionally, an estimated 4.7% of adults will experience a panic disorder in their lifetime (NIMH). Unfortunately, both disorders have high rates of becoming chronic and require difficult treatment programs and medications with adverse side effects.

Click here for the full article.

Fast Company Most Innovative Companies of 2023

Freespira Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023

Medscape_Logo

‘New Kid on the Block’ May Help Relieve PTSD, Panic Disorder

Post

Meditation, Medication or Therapy: The World of PTSD Treatment Continues to Expand